Feladilimab (Anti-ICOS / CD278)
Feladilimab (Anti-ICOS/CD278) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has potential for its use in cancer research. MW: 145.5 KD.
| Trivial name | GSK3359609 |
| Catalog Number | A2462 |
| CAS# | 2252518-85-5 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/feladilimab-anti-icos-cd278.html |